HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani

AIDS

Volumn 14, Issue 8, 2000, Pages 921-929

  Wolday, Dawit ^a   Berhe, Nega ^b   Britton, Sven ^b   Akuffo, Hannah ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Box 280 ^*

Author keywords

Cytokines; HIV; Interleukin; Leishmania; T cell; Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIA DONOVANI; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKINS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; TH1 CELLS; TH2 CELLS;

EID: 0034075369     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005260-00003     Document Type: Article

References (41)

1. 1. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional property. Annu Rev Immunol 1989, 7:145-173.
2. - subsets in leishmaniasis. J Cell Biochem 1993, 53:323-328.
3. 3. Carvalho EM, Barrel A, Pedral-Sampaio D, et al. Immunological markers of clinical evolution in children recently infected with Leishmania chagasi donovani. J Infect Dis 1992, 165:535-540.
4. 4. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol 1987, 138:908-913.
5. 5. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD. Absence of gamma-IFN and IL-2 production during active visceral leishmaniasis. J Clin Invest 1985, 76:2066-2069.
6. 6. Holaday BJ, Pompeu MM, Jeronimo S, et al. Potential role for interleukin 10 in the immunosuppression associated with kalaazar. J Clin Invest 1993, 92:2626-2632.
7. 7. Ghalib HG, Piuvezam MR, Skeiky YAW, et al. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993, 92:324-329.
8. - T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 1994, 62:2614-2618.
9. 9. Akuffo HO, Britton SFF. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol 1992, 87:58-64.
10. 10. Akuffo H, Maasho K, Howe R. Natural and acquired resistance to Leishmania: cellular activation of Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of NK cells. Clin Exp Immunol 1993, 94:516-521.
11. 11. Maasho K, Sanchez F, Schurr E, Hailu A, Akuffo H. Indications of the protective role of NK cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun 1998, 66:2698-2704.
12. 12. Trichieri G. Interleukin 12 and its role in the generation of Th1 cells. Immunol Today 1993, 14:335-338.
13. 13. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
14. 14. WHO/UNAIDS. Leishmania and HIV in Gridlock. WHO/CTD/ LEISH/98.9 Add. I, UNAIDS/98.23. Geneva: World Health Organization;1998.
15. 15. Wolday D, Akuffo H, Britton S, Hathaway A, Sander B. HIV-1 inhibits Leishmania-induced cell proliferation, but not TNF-alpha and IL-6 production. Scand J Immunol 1994, 39:380-386.
16. 16. Wolday D, Akuffo H, Fessehaye G, Valantine A, Britton S. Killed and live HIV-1 increases the intracellular multiplication of L. donovani in monocyte-derived cells. Scand J Infect Dis 1998, 30:29-34.
17. 17. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T-cell cytokine responses in persons with tuberculosis and HIV infection. J Clin Invest 1994, 94:2436-2442.
18. 18. Tsegaye A, Messele T, Tilahun T, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999, 6:410-414.
19. 19. Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection. MMWR 1999, 48:29-31.
20. 20. Barcova M, Kacani L, Speth C, Dierich MP. gp41 Envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J Infect Dis 1998, 177:905-913.
21. 21. Schols D, De Clercq E. HIV-1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996, 70:4953-4960.
22. 22. Borghi P, Fantuzzi L, Varano B, et al. Induction of interleukin-10 by HIV-1 and its gp120 protein in human monocytes/macrophages. J Virol 1995, 69:1284-1287.
23. + T lymphocyte by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 1990, 87:2379-2383.
24. 24. Gazzinelli RT, Bala S, Stevens R, et al. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 1995, 155:1565-1574.
25. 25. Graziosi C, Pantaleo G, Grantt KR, et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994, 265:248-252.
26. 26. Maggi E, Mazzetti M, Ravina A, et al. Ability of HIV-1 to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994, 265:244-248.
27. 27. Hu R, Oyaizu N, Kalyanaraman VS, Pahwa S. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin Immunol Immunopathol 1994, 73:245-251.
28. 28. Ghalib HW, Whittle JA, Kubin M, et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 1995, 154:4623-4629.
29. 29. Wei XQ, Leung BP, Niedbala W, et al. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol 1999, 163:2821-2828.
30. 30. Chehimi J, Starr SE, Frank SE, et al. Impaired IL-12 production in HIV-infected patients. J Exp Med 1994, 179:1361-1365.
31. 31. Cenini P, Berhe N, Hailu A, McGiness K, Frommel D. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 1993, 168:986-993.
32. 32. Sundar S, Reed SG, Sharma S, Mehrotra A, Murray HW. Circulating T helper 1 (Th1) cell-and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997, 56:522-525.
33. 34. de Waal Malefyt R, Abrams J, Bennett B, Figodor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
34. 35. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell.IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095.
35. 36. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991, 174:915-924.
36. 37. Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994, 93:768-775.
37. 38. Ameglio F, Cordiali Fei P, Solmone M, et al. Serum IL-10 levels in HIV-positive subjects: Correlation with CDC stages. J Biol Reg Homeost Agents 1994, 8:48-52.
38. 39. Cacopardo B, Nigro L, Preiser W, et al. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans Roy Soc Trop Med Hyg 1996, 90:434-435.
39. 40. Medrano FJ, Rey C, Leal M, et al. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clin Exp Med 1998, 114:403-407.
40. 41. Marshal JD, Aste-Amezaga M, Chehim SS, Murphy M, Olsen H, Trinchieri G. Regulation of human IL-18 mRNA expression, Clin Immunol 1999, 90:15-21.
41. 42. Navikas V, Link J, Wahren B, Persson C, Link H. Increased levels of interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994, 96:59-63.